Details

Autor(en) / Beteiligte

• Cantello, Roberto
• Rossi, Simone
• Varrasi, Claudia
• Ulivelli, Monica
• Civardi, Carlo
• Bartalini, Sabina
• Vatti, Giampaolo
• Cincotta, Massimo
• Borgheresi, Alessandra
• Zaccara, Gaetano
• Quartarone, Angelo
• Crupi, Domenica
• Laganà, Angela
• Inghilleri, Maurizio
• Giallonardo, Anna Teresa
• Berardelli, Alfredo
• Pacifici, Loredana
• Ferreri, Florinda
• Tombini, Mario
• Gilio, Francesca
• Quarato, Pierpaolo
• Conte, Antonella
• Manganotti, Paolo
• Bongiovanni, Liugi Giuseppe
• Monaco, Francesco
• Ferrante, Daniela
• Rossini, Paolo Maria

Titel

Slow Repetitive TMS for Drug‐resistant Epilepsy: Clinical and EEG Findings of a Placebo‐controlled Trial

Ist Teil von

• Epilepsia (Copenhagen), 2007-02, Vol.48 (2), p.366-374

Ort / Verlag

Malden, USA: Blackwell Publishing Inc

Erscheinungsjahr

2007

Link zum Volltext

Quelle

Wiley Online Library

Beschreibungen/Notizen

• Purpose: To assess the effectiveness of slow repetitive transcranial magnetic stimulation (rTMS) as an adjunctive treatment for drug‐resistant epilepsy. Methods: Forty‐three patients with drug‐resistant epilepsy from eight Italian Centers underwent a randomized, double‐blind, sham‐controlled, crossover study on the clinical and EEG effects of slow rTMS. The stimulus frequency was 0.3 Hz. One thousand stimuli per day were given at the resting motor threshold intensity for 5 consecutive days, with a round coil at the vertex. Results:“Active” rTMS was no better than placebo for seizure reduction. However, it decreased interictal EEG epileptiform abnormalities significantly (p < 0.05) in one‐third of the patients, which supports a detectable biologic effect. No correlation linked the rTMS effects on seizure frequency to syndrome or anatomic classification, seizure type, EEG changes, or resting motor threshold (an index of motor cortex excitability). Conclusions: Although the antiepileptic action was not significant (p > 0.05), the individual EEG reactivity to “active” rTMS may be encouraging for the development of more‐powerful, noninvasive neuromodulatory strategies.